Literature DB >> 27381982

Protein kinase B (AKT) regulates SYK activity and shuttling through 14-3-3 and importin 7.

Dara K Mohammad1, Beston F Nore2, Manuela O Gustafsson3, Abdalla J Mohamed4, C I Edvard Smith5.   

Abstract

The Protein kinase B (AKT) regulates a plethora of intracellular signaling proteins to fine-tune signaling of multiple pathways. Here, we found that following B-cell receptor (BCR)-induced tyrosine phosphorylation of the cytoplasmic tyrosine kinase SYK and the adaptor BLNK, the AKT/PKB enzyme strongly induced BLNK (>100-fold) and SYK (>100-fold) serine/threonine phosphorylation (pS/pT). Increased phosphorylation promoted 14-3-3 binding to BLNK (37-fold) and SYK (2.5-fold) in a pS/pT-concentration dependent manner. We also demonstrated that the AKT inhibitor MK2206 reduced pS/pT of both BLNK (3-fold) and SYK (2.5-fold). Notably, the AKT phosphatase, PHLPP2 maintained the activating phosphorylation of BLNK at Y84 and increased protein stability (8.5-fold). In addition, 14-3-3 was required for the regulation SYK's interaction with BLNK and attenuated SYK binding to Importin 7 (5-fold), thereby perturbing shuttling to the nucleus. Moreover, 14-3-3 proteins also sustained tyrosine phosphorylation of SYK and BLNK. Furthermore, substitution of S295 or S297 for alanine abrogated SYK's binding to Importin 7. SYK with S295A or S297A replacements showed intense pY525/526 phosphorylation, and BLNK pY84 phosphorylation correlated with the SYK pY525/526 phosphorylation level. Conversely, the corresponding mutations to aspartic acid in SYK reduced pY525/526 phosphorylation. Collectively, these and previous results suggest that AKT and 14-3-3 proteins down-regulate the activity of several BCR-associated components, including BTK, BLNK and SYK and also inhibit SYK's interaction with Importin 7.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  14-3-3; AKT/PKB; BLNK; Importin 7; Nuclear translocation; PHLPP; SYK

Mesh:

Substances:

Year:  2016        PMID: 27381982     DOI: 10.1016/j.biocel.2016.06.024

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Terminating B cell receptor signaling.

Authors:  Dara K Mohammad; Beston F Nore; C I Edvard Smith
Journal:  Oncotarget       Date:  2017-12-06

2.  Expression of Syk and MAP4 proteins in ovarian cancer.

Authors:  Siwei Zhang; Suha Deen; Sarah J Storr; Anqi Yao; Stewart G Martin
Journal:  J Cancer Res Clin Oncol       Date:  2019-02-08       Impact factor: 4.553

Review 3.  Targeting nuclear import and export in hematological malignancies.

Authors:  Boaz Nachmias; Aaron D Schimmer
Journal:  Leukemia       Date:  2020-07-05       Impact factor: 11.528

4.  The Serine/Threonine Protein Phosphatase 2A (PP2A) Regulates Syk Activity in Human Platelets.

Authors:  Stephanie Makhoul; Elena Kumm; Pengyu Zhang; Ulrich Walter; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.